Continuum Advisory’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7
Closed -$2.13K 1119
2025
Q1
$2.13K Sell
7
-1
-13% -$336 ﹤0.01% 1334
2024
Q4
$2.66K Buy
8
+1
+14% +$339 ﹤0.01% 1329
2024
Q3
$2.34K Hold
7
﹤0.01% 1378
2024
Q2
$2.88K Hold
7
﹤0.01% 1210
2024
Q1
$2.79K Buy
+7
New +$2.46K ﹤0.01% 1207

Other funds holding MEDP

Continuum Advisory's MEDP Position: Q2 2025 in Review

Continuum Advisory sold out of Medpace (MEDP) in Q2 2025, closing a stake of 7 shares — an estimated $2.13K sold.

Continuum Advisory first reported a position in MEDP in Q1 2024 and held it in 5 quarters. The position peaked at $2.88K in Q2 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

  • Continuum Advisory reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 7 Medpace shares in Q2 2025, an estimated $2.13K.
  • Continuum Advisory first reported a position in Medpace in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's Medpace position peaked at $2.88K in Q2 2024.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.